Regulatory T cells and autoimmunity;Regulačné T-bunky a autoimunita

Rheumatologia

Volumn 16, Issue 4, 2002, Pages 189-193

  Bucova, Maria ^a  

^a Imunol Ustav Lekarskej Fakulty UK   (Slovakia)

Author keywords

Autoimmunity; Cytokine; Polarization; TH1; TH2 regulatory T cells

Indexed keywords

CYTOKINE;

AUTOIMMUNITY; CELL POLARITY; IMMUNE RESPONSE; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

EID: 0036915295     PISSN: 12101931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Akbari, O., DeKruyff, R.H., Umetsu, D.T.: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol, 2, 2001, č. 8, s. 725-731.
2. Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O. et al.: CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol, 166, 2001, č. 5, s. 3008-3018.
3. Asano, M., Toda, M., Sakaguchi, N. et al.: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med, 184, 1996, č. 2, s. 387-396.
4. Baecher-Allan, C., Brown, J.A., Freeman, G.J. et al.: CD4+CD25 high regulatory cells in human peripheral blood. J Immunol, 167, 2001, č. 3, s. 1245-1253.
5. H2 polarizácia. Rheumatologia, 16, 2002, č. 3, s. 117-124.
6. Burkhart, C., Liu, G.Y., Anderton, S.M. et al.: Peptide-induced T cell regulation of experimental autoimmune encephalomyclitis: A role for IL-10. Int Immunol, 11, 1999, č. 10, s. 1625-1634.
7. Caspi, R.R.: IL-12 in autoimmunity. Short analytical review. Clin Immunol Immunopathol, 88, 1998, č. 1, s. 4-13.
8. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol, 30, 2000, č. 6, s. 1538-1543.
9. Chai, J.G., Bartok, I., Chandler, P. et al.: Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol, 29, 1999, č. 2, s. 686-692.
10. H2-specific response in vivo. J. Immunol, 165, 2000, č. 9, s. 4848-4853.
11. Dhodapkar, M.V., Steinman, R.M., Krasovsky, J. et al.: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med, 193, 2001, č. 2, s. 233-238.
12. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, 389, 1997, č. 6652, s. 737-742.
13. Hanninen, A., Harrison, L.C.: Gamma delta T cells as mediators of mucosal tolerance: The autoimmune diabetes model. Immunol Rev, 173, 2000, s. 109-119.
14. Hara, M., Kingsley, C.I., Niimi, M. et al.: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol, 166, 2001, č. 6, s. 3789-3796.
15. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med, 192, 2000, č. 9, s. 1213-1222.
16. H2 subsets: Paradigms lost? Immunol Today, 16, 1995, č. 8, s. 374-379.
17. Levings, M.K., Sangregorio, R., Galbiati, F. et al.: IFN-alpha and IL-10 induce the differentiation of human type 1 regulatory cells. J Immunol, 166, 2001, č. 9, s. 5530-5539.
18. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med, 193, 2001, č. 11, s. 1295-1302.
19. Miller, A., Lider, O., Roberts, A.B. et al.: Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA, 89, 1992, č. 1, s. 421-425.
20. Murphy, E., Shibuya, K., Hosken, N. et al.: Reversibility of T helper 1 and 2 populations is lost after long term stimulation. J Exp Med, 183, 1996, č. 3, s. 901-913.
21. H2 populations. Int Immunol, 7, 1995, č. 5, s. 869-875.
22. + regulatory cells that control intestinal inflammation. J Exp Med, 192, 2000, č. 2, s. 295-302.
23. Read, S., Powrie, F.: CD4+ regulatory T cells. Curr Opin Immunol, 13, 2001, č. 6, s. 644-649.
24. Roncarolo, M.G., Levings, M.K.: The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol, 12, 2000, č. 6, s. 676-683.
25. Seo, N., Tokura, Z., Takigawa, M. et al.: Depletion of IL-10 and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol, 163, 1999, č. 1, s. 242-249.
26. Steinbrink, K., Jonuleit, H., Knop, J. et al.: Induction of tolerance by IL-10-treated dendritic cells. J Immunol, 159, 1997, č. 10, s. 4772-4780.
27. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol, 31, 2001, č. 4, s. 1247-1254.
28. Taams, L.S., van Rensen, A.J., Poelen, M.C. et al.: Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol, 28, 1998, č. 9, s. 2902-2912.
29. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol, 10, 1998, č. 12, s. 1969-1980.
30. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen (CTLA) 4. J Exp Med, 192, 2000, č.2, s. 303-309.
31. + Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med, 188, 1998, č. 2, s. 287-296.
32. + immunoregulatory T cells is antigen nonspecific. J Immunol, 164, 2000, č. 1, s. 183-190.
33. + T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol, 167, 2001, č. 1, s. 188-195.
34. Vendetti, S., Chai, J.G., Dyson, J. et al.: Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol, 165, 2000, č. 3, s. 1175-1181.
35. 2-secreting B-lymphocytes. Immunology, 71, 1990, č. 4, s. 566-572.
36. + regulatory T cells from human peripheral blood. J Immunol, 166, 2001, č. 12, s. 7282-7289.